Identify Genes Who Forecast Response To Breast Cancer Procedure

Scientists from the Stockholm School of Karolinska have recognized the genes that predict response to postoperative procedure of breast cancer patients within four years after the operation, this is a breakthrough science for cancer patients.

Those responsible for the study sets out that micro array DNA technology could be used to start new treatments available and dispense with these patients to avoid sharp and damaged therapies. Researchers examined 150 patients for breast cancer hereditary profiles using the study of micro array DNA.

These samples were hereditary signatures of 35 patients who had a poor omen, determined as the deterioration or death by any provenance in the four years since. The remaining 125 patients were specified as of good omen.

Scientists also used gene expression profiles for removing patients who demonstrated good results with and without postoperative therapy and those whose tumors had no response to treatment.

An investigation of the genes listed in tumors of 150 patients revealed that 64 genes were able to use to separate the good and bad progression patients. Scientists then rehearsed the predictive group of 64 genes identified three used markers to medical level value.

Handling schemas of expression of the 64 certain genes were better prognosis than with prognostic markers used rates currently, also lack of judgment to provide appropriate for patients with breast cancer treatment demonstrates the need to develop new techniques.



 

   

Try our free medication and pharmacy search engine! Just enter the name of the medication you are looking for (i.e. Phentermine, Vicodin, Xanax, Lortab, Valium, etc.). Listings are not verified by FindRxOnline.com and filtered from publicly available data. In addition to online pharmacies, searches may also provide other results. You must be 21 years or older to use this search engine.

Buy Discount Prescription Drugs from Online Consultation Services & Foreign Pharmacies